Scienture Holdings, Inc. (SCNX)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
Market Cap: $4.91M
Last updated: Nov 17, 2026 at 4:10 PM ET
Scienture Holdings, Inc. (SCNX) Stock Chart
Scienture Holdings (SCNX) has a latest price of $2.78 on Nov 17, 2026, 85.2% below its 52-week high of $18.75. Its price fell 82.7% over the past 12 months. The month-end price fell 99.8% over the 10 years through Oct 2026, a compound annual decline of 45.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $2,967.92 in Sep 2019 and its lowest $3.22 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SCNX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SCNX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 76.5%, and over 6 months it fell 71.5%. The month-end price fell 97.8% over the 3 years through Oct 2026, a compound annual decline of 71.9%.
| Period | Change |
|---|---|
| 1 month | -4.8% |
| 3 months | -76.5% |
| 6 months | -71.5% |
| 12 months | -82.7% |
| 12 months, with dividends | -82.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -97.8% | -71.9% |
| 5 years | -99.8% | -71.1% |
| 10 years | -99.8% | -45.8% |
Price by Year
Its best calendar year was 2024, when the price rose 16.4%, and its weakest was 2025, when it fell 91.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.22 | -74.7% |
| 2025 | $12.75 | -91.6% |
| 2024 | $151.25 | +16.4% |
| 2023 | $129.91 | -13.9% |
| 2022 | $150.90 | -82.9% |
| 2021 | $884.56 | -55.4% |
| 2020 | $1,982.76 | -19.8% |
| 2017 | $1,011.79 | -2.2% |
Trading Range
The price is 41.2% below its 50-day average of $4.73 and 67.8% below its 200-day average of $8.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.78 | |
| 52-week high | $18.75 | -85.2% |
| 52-week low | $2.64 | +5.3% |
| 50-day average | $4.73 | -41.2% |
| 200-day average | $8.63 | -67.8% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.68 |
| Largest fall, 1 year | -83.0% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SCNX
What is SCNX's 1-year price change?
Scienture Holdings's price fell 82.7% over the past 12 months. With dividends included, the 12-month total return was -82.7%.
What is SCNX's 5-year price change?
Scienture Holdings's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 71.1%. These figures leave out dividends.
What is SCNX's 52-week high and low?
Scienture Holdings's 52-week high is $18.75 and its 52-week low is $2.64. Its latest price of $2.78 on Nov 17, 2026 is 85.2% below the high.
What is SCNX's beta?
Scienture Holdings's 1-year beta against the S&P 500 is 1.68, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 83.0%.
Is the SCNX chart free?
Yes. Advanced Charting for SCNX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SCNX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors